Marie-Catherine Francino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marie-Catherine Francino has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Alain Turcant
Centre Hospitalier Universitaire
1 shared publication Dominique Perrotin
CHRU de Tours, réanimation médicale, 2 Boulevard Tonnellé, Tours Cedex 9, France
1 shared publicationJulie Badin
CHRU de Tours, réanimation médicale, 2 Boulevard Tonnellé, Tours Cedex 9, France
1 shared publicationMarie Bretaudeau Deguigne
CHU de Angers, Centre Antipoison Toxicovigilance, 4 rue Larrey, Angers Cedex 9, France
1 shared publication
Latest Publications
- 16 February 2012
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 50 (3) , 215-217
Hypoglycaemia: A little known effect of Venlafaxine overdose
We report the case of a 39-year-old woman who presented with serotonin syndrome and hypoglycaemia likely due to intoxication with a very high dose of venlafaxine. This case of venlafaxine-associated hypoglycaemia was treated first by glucose perfusion, but despite large doses, hypoglycaemia recurred. Blood glucose normalized after injection of octreotide, eliminating the need for hypertonic glucose. Octreotide has been shown to decrease glucose requirements and the number of hypoglycaemic episodes in patients with sulfonylurea-induced hypoglycaemia but, to our knowledge, its ability to resolve hypoglycaemic episodes due to massive venlafaxine overdose has not yet been described.
- 16 February 2012
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 50 (3) , 215-217
Hypoglycaemia: A little known effect of Venlafaxine overdose
We report the case of a 39-year-old woman who presented with serotonin syndrome and hypoglycaemia likely due to intoxication with a very high dose of venlafaxine. This case of venlafaxine-associated hypoglycaemia was treated first by glucose perfusion, but despite large doses, hypoglycaemia recurred. Blood glucose normalized after injection of octreotide, eliminating the need for hypertonic glucose. Octreotide has been shown to decrease glucose requirements and the number of hypoglycaemic episodes in patients with sulfonylurea-induced hypoglycaemia but, to our knowledge, its ability to resolve hypoglycaemic episodes due to massive venlafaxine overdose has not yet been described.